Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Alexeeff

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|July 5, 2023
Screening for Prostate CancerJoseph Presti, Stacey Alexeeff, Andrew L Avins
Journal of General Internal Medicine|July 14, 2021
Impact of 2012 Prostate Cancer Screening StatementJoseph Presti, Stacey Alexeeff, Andrew L Avins
Urology Practice|May 5, 2023
Reply by AuthorsBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Urology Practice|June 24, 2024
Reply by AuthorsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Urology Practice|May 5, 2023
Race-Specific Trends in Prostate Cancer Screening and Presentation before and after the 2012 United States Preventive Services Task Force StatementBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Urology Practice|June 24, 2024
Prospective Evaluation of the Kaiser Permanente Prostate Cancer Risk Calculator in Biopsy-Naïve Men With Mild PSA ElevationsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Journal of General Internal Medicine|October 27, 2020
Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Journal of General Internal Medicine|December 11, 2019
Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|June 16, 2020
Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk CalculatorJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|May 8, 2021
Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral populationJoseph C Presti, Stacey Alexeeff, Brandon Horton, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|July 5, 2023
Screening for Prostate CancerJoseph Presti, Stacey Alexeeff, Andrew L Avins
Journal of General Internal Medicine|July 14, 2021
Impact of 2012 Prostate Cancer Screening StatementJoseph Presti, Stacey Alexeeff, Andrew L Avins
Urology Practice|May 5, 2023
Reply by AuthorsBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Urology Practice|June 24, 2024
Reply by AuthorsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Urology Practice|May 5, 2023
Race-Specific Trends in Prostate Cancer Screening and Presentation before and after the 2012 United States Preventive Services Task Force StatementBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Urology Practice|June 24, 2024
Prospective Evaluation of the Kaiser Permanente Prostate Cancer Risk Calculator in Biopsy-Naïve Men With Mild PSA ElevationsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Journal of General Internal Medicine|October 27, 2020
Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Journal of General Internal Medicine|December 11, 2019
Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|June 16, 2020
Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk CalculatorJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|May 8, 2021
Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral populationJoseph C Presti, Stacey Alexeeff, Brandon Horton, et al.
Pageof 8